HCAT

Health Catalyst Inc.

Price

$1.61

return (12m)

-56.03%

p/e

-0.44

p/bv

1.17

DIVIDEND YIELD

0.00%

HCAT price

Health Catalyst

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment HCAT

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-22.65%

3 months

16.30%

1 year

-56.03%

2 years

-76.47%

5 years

-97.00%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals HCAT

Valuation

P/E

-0.44

Sector -0.16

Industry 2.77

P/BV

1.17

Sector 1.93

Industry 2.37

P/Revenue (PSR)

0.40

Sector 1.67

Industry 1.97

EV/EBITDA

Sector -55.30

Industry -73.25

EV/EBIT

Sector -488.87

Industry -73.47

P/EBITDA

Sector -178.48

Industry -262.99

P/EBIT

Sector -214.62

Industry -268.43

P/Total Assets

0.33

Sector 0.91

Industry 1.07

P/Net Current Assets

-12.53

Sector -24.70

Industry -5.25

P/Working Capital

0.75

Sector -5.32

Industry 3.11

EPS

-3.58

Sector -0.79

Industry -0.61

BVPS

1.36

Sector 3.79

Industry 4.57

Efficiency

Gross Margin

50.48%

Sector 48.28%

Industry 50.49%

EBITDA Margin

0.00%

Sector -5,407,515.68%

Industry -10.73%

EBIT Margin

0.00%

Sector -62.93%

Industry -21.31%

Operating Margin

-84.36%

Sector -23.12%

Industry -27.36%

Net Profit Margins

-90.62%

Sector -27.40%

Industry -30.91%

Asset Turnover

0.20

Sector 0.13

Industry 0.15

Profitability

ROE

-262.65%

Sector -31.93%

Industry -27.86%

ROA

-73.85%

Sector -28.25%

Industry -27.56%

ROIC

0.00%

Sector -317.33%

Industry -57.09%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

2.70

Sector 1.85

Industry 1.98

Net Debt / EBITDA

Sector -42.46

Industry -72.45

Net Debt / EBIT

Sector -37.26

Industry -7.11

Net Debt / Equity

1.51

Sector -1.04

Industry -0.12

Gross Debt / Equity

1.51

Sector -0.72

Industry 0.10

Equity/Assets

0.28

Sector 0.43

Industry 0.45

Liabilities/Assets

0.72

Sector 0.48

Industry 0.51

Growth

5Y Revenue CAGR

3.85%

Sector -

Industry -

5Y Earnings CAGR

11.57%

Sector -

Industry -

Fundamentals HCAT

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
HCAT Health Catalyst Inc.	$1.61	-56.50%	0.00%	-0.44	1.17	-262.65%	-90.62%
SLP Simulations Plus Inc.	$18.42	31.85%	0.00%	45.32	2.65	5.84%	9.90%
OPRX OptimizeRx Corporation	$7.87	-55.11%	0.00%	31.60	1.11	3.51%	4.66%
RVTY Revvity Inc.	$127.54	43.41%	0.22%	58.32	1.93	3.31%	8.22%
LLY Eli Lilly and Compay	$1,169.97	61.21%	0.52%	41.58	-	-%	33.53%
ISRG Intuitive Surgical Inc.	$371.80	-21.09%	0.00%	41.88	7.23	17.26%	28.62%
SNY Sanofi	$44.84	-7.34%	3.87%	7.43	1.37	18.43%	13.81%
NVS Novartis AG	$153.04	22.95%	1.96%	28.21	7.75	27.47%	26.57%
TMO Thermo Fisher Scientific Inc.	$618.91	27.34%	0.29%	33.36	4.42	13.26%	15.08%
ABT Abbott Laboratories	$112.42	-12.47%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$91.17	3.05%	3.09%	24.60	2.36	9.59%	13.20%
GSK GlaxoSmithKline PLC	$50.24	31.67%	3.42%	15.92	4.50	28.24%	14.54%
BSX Boston Scientific Corp.	$46.77	-55.83%	0.00%	17.71	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$91.75	-20.34%	0.00%	21.60	6.32	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$553.20	-13.68%	0.00%	38.78	27.41	70.67%	25.03%
RMD ResMed Inc.	$238.60	-14.30%	1.04%	22.12	5.18	23.41%	27.44%
DHR Danaher Corporation	$215.43	5.71%	0.67%	37.88	2.88	7.61%	15.95%
HCA HCA Healthcare Inc.	$419.06	4.14%	0.70%	12.08	-29.56	-244.72%	10.07%
COHR Coherent Inc.	$282.51	211.44%	0.00%	115.66	4.75	4.11%	6.85%
PHG Koninklijke Philips NV	$26.71	0.25%	3.68%	20.31	1.99	9.80%	6.30%
SYK Stryker Corp.	$327.50	-15.63%	1.06%	33.67	5.23	15.55%	14.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

HCAT Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Health Catalyst

Health Catalyst Inc.

Average Investor10 user rating

4.0 (0 people)

United States

15 years

Founded: 2011

2019

Time since IPO - 7 years

1.000

Employees

Health Catalyst Inc. (United States) is listed on the Nasdaq and has a market capitalization of $117.66 million, with shareholders equity totaling $100.83 million.

The company employs approximately 1.000 people and operates in the Health sector, within the Health Technology industry.

Over the past 12 months, Health Catalyst Inc. reported $292.25 million in revenue, generating net income of $-264.83 million.

Key financial metrics include a P/E ratio of -0.44, a price-to-book (P/B) ratio of 1.17, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker HCAT.

Market cap

$117.66 million

Net worth

$100.83 million

$100,830,000.00

Assets

$358.60 million

$358,600,000.00

Total Shares Outstanding

74.00 million

74,000,000

Average Daily Trading Volume

$1.17 million

$1,169,560.88

Sector

Health

Industry

Health Technology

HCAT

HCAT revenue and profits

Financial Results HCAT

DRAG THE FRAME TO SEE MORE DATA

HCAT cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.51 31,87% (12M)

P/E

-0.84

2.83%

ROE

-178.93%

P/BV

1.51

CI - Cigna

$279.22 --4,61% (12M)

P/E

10.77

2.20%

ROE

16.04%

P/BV

1.73

CNC - Centene

$64.37 121,66% (12M)

P/E

-6.35

0.00%

ROE

-22.56%

P/BV

1.43

HUM - Humana

$390.51 30,46% (12M)

P/E

35.82

0.92%

ROE

6.72%

P/BV

2.41

SNY - Sanofi

$44.84 --5,80% (12M)

P/E

7.43

3.87%

ROE

18.43%

P/BV

1.37

LLY - Eli Lilly

$1,169.97 60,50% (12M)

P/E

41.58

0.52%

ROE

P/BV

HCA - HCA Healthcare

$419.06 4,42% (12M)

P/E

12.08

0.70%

ROE

-244.72%

P/BV

-29.56

NVS - Novartis

$153.04 23,28% (12M)

P/E

28.21

1.96%

ROE

27.47%

P/BV

7.75